Align Technology (ALGN)
(Delayed Data from NSDQ)
$236.97 USD
-1.09 (-0.46%)
Updated Oct 3, 2024 03:59 PM ET
After-Market: $232.00 -4.97 (-2.10%) 5:10 PM ET
4-Sell of 5 4
D Value D Growth A Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$236.97 USD
-1.09 (-0.46%)
Updated Oct 3, 2024 03:59 PM ET
After-Market: $232.00 -4.97 (-2.10%) 5:10 PM ET
4-Sell of 5 4
D Value D Growth A Momentum D VGM
Zacks News
Edwards Lifesciences (EW) SAPIEN 3 THV Gets FDA Approval
by Zacks Equity Research
Edwards Lifesciences Corporation (EW) recently announced the receipt of FDA approval for aortic and mitral valve-in-valve procedures using SAPIEN 3 transcatheter heart valve (THV).
Tenet Healthcare Prices New Notes to Repay Existing Debts
by Zacks Equity Research
Tenet Healthcare Corporation (THC) recently priced the previously announced private offering of newly issued notes.
QIAGEN Strengthens Cancer Research Foothold on New License
by Zacks Equity Research
QIAGEN N.V. (QGEN) has received a worldwide license for biomarkers to be used in identifying patients who may have benefited from immune-oncology (I-O) therapies in cancer treatment.
Myriad Genetics BRACAnalysis CDx in OlympiAD Results Positive
by Zacks Equity Research
Myriad Genetics, Inc. (MYGN), a leading molecular diagnostics and personalized medicine company recently unveiled positive data pertaining to its BRACAnalysis CDx test.
Align Sets Up Manufacturing Center in China, Grows in APAC
by Zacks Equity Research
Align Technology (ALGN) has recently inaugurated a new Invisalign treatment planning facility in Chengdu, China.
Abbott Laboratories at 52-Week High on Product Line, Buyouts
by Zacks Equity Research
Share price of IL-based Abbott Laboratories (ABT) scaled a new 52-week high of $46.55 on Jun 2, eventually closing a bit lower at $46.50.
QIAGEN & Bristol-Myers Squibb Partner on Cancer Research
by Zacks Equity Research
QIAGEN N.V. (QGEN) has made significant advancement in the field of cancer research through the use of its revolutionary next-generation sequencing (NGS) technology.
Five Stocks Rocketing Higher on Huge Momentum
by David Bartosiak
The bears were sent running, screaming towards their caves today as the market started strong and didn???t look back at all
Align Technology Upgrades iTero Element Intraoral Scanners
by Zacks Equity Research
Based in California, leading dental product maker Align Technology, Inc. (ALGN) recently announced a software upgrade to its iTero Element intraoral scanners.
UnitedHealth Unit Taps Connecticut Orthopedic Surgery Market
by Zacks Equity Research
Surgical Care Affiliates, Inc, a part of UnitedHealth Group's Optum unit, recently partnered with Western Connecticut Orthopedic Surgery Center by making an equity investment in the latter.
Why WellCare (WCG) Stock Should Be in Your Portfolio Now
by Zacks Equity Research
Leading managed care company WellCare Health Plans, Inc.'s (WCG) business strategies should continue to support growth.
Align Technology Rises with Invisalign, SmartTrack Patents
by Zacks Equity Research
Align Technology (ALGN) has received two U.S. Patents from the United States Patent and Trademark Office (USPTO) for its SmartTrack clear aligner material.
Quest Diagnostics Poised on Solid Q1 Results Despite Woes
by Zacks Equity Research
On May 22, we issued an updated research report on Quest Diagnostics, Inc. (DGX), a major commercial laboratory services provider.
Medtronic (MDT) RESOLUTE ONYX Meets Primary Study Endpoint
by Zacks Equity Research
Medtronic plc (MDT) recently announced favorable outcome on its Resolute Onyx Drug-Eluting Stent.
Edwards Lifesciences SAPIEN 3 Heart Valve Data Positive
by Zacks Equity Research
Edwards Lifesciences Corporation (EW) recently unveiled positive one-year data on its SAPIEN 3 transcatheter heart valve.
Is the Time Ripe to Invest in Paylocity Holding (PCTY)?
by Zacks Equity Research
If you are planning your portfolio, then Paylocity Holding Corporation (PCTY) can be a wise pick.
Why Align Technology (ALGN) Could Be an Impressive Growth Stock
by Zacks Equity Research
A company that might be well-positioned for future earnings growth is Align Technology, Inc. (ALGN).
Top Stock Picks for the Week of May 8th
by Panel Of Zacks Experts
Two Strong Buys With Two Strong Stories.
Align Technology Invisalign Sales Strong, Currency Woes Stay
by Zacks Equity Research
On May 5, we issued an updated research report on Align Technology (ALGN), which manufactures a system of clear aligner therapy.
Align Technology, Community Health Systems, Ultra Clean Holdings, Tyson Foods and Huntsman highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Align Technology, Community Health Systems, Ultra Clean Holdings, Tyson Foods and Huntsman highlighted as Zacks Bull and Bear of the Day
Bull of the Day: Align Technology (ALGN)
by Kevin Cook
Clearly, investors will continue to smile with this 25% grower in their portfolios
Zacks Investment Ideas feature highlights: Regeneron, Edwards Lifesciences, Alexion Pharmaceuticals, Align Technology and Centene
by Zacks Equity Research
Zacks Investment Ideas feature highlights: Regeneron, Edwards Lifesciences, Alexion Pharmaceuticals, Align Technology and Centene
Align Technology (ALGN) Rises: Stock Adds 7.5% in Session
by Zacks Equity Research
Align Technology, Inc. (ALGN) rose over 7% in the last trading session.
Will Align Technology (ALGN) Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Align Technology, Inc. (ALGN)
New Strong Buy Stocks for May 2nd
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday